Newsletter

July 2018 Scorecard

The July 2018 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

Regeneron Pharmacueticals and Teva Pharmaceutical Report Positive Topline Phase 3 Clinical Trial Results of Fasinumab

On August 16, Regeneron Pharmaceuticals, Inc. (REGN) and Teva Pharmaceutical Industries Ltd. (TEVA) announced positive topline results from a Phase 3 clinical trial of Fasinumbab in patients with chronic pain from osteoarthritis of the knee or hip. After 16 weeks, the study met both co-primary endpoints as well as all key secondary endpoints. Patients treated […]

Read more...

Strongbridge Biopharma Reports Positive Results in Phase 3 SONICS Study of RECORLEV

On August 8, Strongbridge Biopharma plc (SBBP) announced top-line results from its Phase 3 SONICS study evaluating RECORLEVTM(levoketoconazole) for the treatment of endogenous Cushing’s syndrome. The open-label, single-arm SONICS study produced statistically significant results of its pre-specified primary endpoint. At six months, 30% of patients demonstrated a normalization rate of Urinary Free Cortisol. Sonal alerted […]

Read more...

Horizon Pharma Reports Second Quarter Earnings and Increases Annual Guidance

Horizon Pharma plc (HZNP) reported its second-quarter 2018 earnings on August 8. Net sales increased by 4.6% due to strong growth for its orphan and rheumatology medicines. The company increased its annual adjusted EBITDA guidance to between $400 million and $420 million. Horizon Pharma has realigned its operating structure into two segments so that it […]

Read more...

Fortune Brands Home & Security Increases Annual Earnings Outlook on Strong Second-Quarter Sales Results

Fortune Brands Home & Security, Inc. (FBHS) announced its second-quarter 2018 earnings on July 26. Sales increased 5% year-over-year to $1.4 billion. The company increased its guidance for annual EPS before charges/gains to between $3.62 and $3.72.   Sonal issued an alert to subscribers at 4:05 pm. The next trade was for $53.97 at 4:06 […]

Read more...

Check Point Software Technologies Expands Current Share Repurchase Program

Check Point Software Technologies Ltd. (CHKP) announced on July 25 that the company’s Board of Directors authorized a major expansion of the current share repurchase program. The updated repurchase plan is effective immediately and increases the quarterly repurchase 30% to $325 million in outstanding shares. The overall repurchase plan increased 100% to a total of […]

Read more...